The hematology and oncology staff at Mayo Clinic's campus in Rochester, Minnesota, is composed of more than 100 members with diverse clinical and research interests.
Within Mayo Clinic's Division of Hematology, unique disease-oriented groups exist to focus the research efforts and improve the level of care provided by each member of the group. The Department of Oncology includes specialists and subspecialists experienced in treatment of all types of cancers, from the common to the unusual. Clinical expertise is integrated with the newest forms of established and experimental diagnostic and therapeutic methods, including chemotherapy, radiation therapy, immunotherapy and surgery.
Mayo Clinic Cancer Center is a leader in translating knowledge gained from research on cancer into effective improvements in the care of patients with cancer and their families. The center is one of the largest in the United States and one of 69 U.S. medical centers that have been designated as National Cancer Institute (NCI) cancer centers. About 45 of these centers, including Mayo Clinic, have met the even more rigorous standards of a comprehensive cancer center.
Annually, Mayo Clinic evaluates more than 20,000 patients with diverse solid tumors and hematologic disorders, along with a significant number of patients with nonmalignant hematologic disorders.
Mayo Clinic actively participates in clinical trials of newer therapies for malignant disorders, including many phase I and phase II studies. In addition to intramural protocols, other trials involve cooperative efforts with a variety of groups, including:
Mayo Clinic also operates the Mayo Comprehensive Hemophilia Center, one of the few National Institutes of Health-designated regional centers. The center includes a coagulation laboratory that has very diverse clinical and research pursuits.
Many prominent professors visit Mayo Clinic each year. They present their work during lectures and participate in hospital rounds.
May 25, 2016